Alissa Cooper's No Objection on draft-ietf-imapapnd-appendlimit-extension-08: (with COMMENT)
"Alissa Cooper" <[email protected]> Tue, 05 Jan 2016 11:10:25 -0800
| Newsgroups | gmane.ietf.imapext |
|---|---|
| Message-ID | <[email protected]> |
Alissa Cooper has entered the following ballot position for draft-ietf-imapapnd-appendlimit-extension-08: No Objection When responding, please keep the subject line intact and reply to all email addresses included in the To and CC lines. (Feel free to cut this introductory paragraph, however.) Please refer to https://www.ietf.org/iesg/statement/discuss-criteria.html for more information about IESG DISCUSS and COMMENT positions. The document, along with other ballot positions, can be found here: https://datatracker.ietf.org/doc/draft-ietf-imapapnd-appendlimit-extension/ ---------------------------------------------------------------------- COMMENT: ---------------------------------------------------------------------- It's unusual to see author names without first initials in the document header. Not sure if that was intentional but seems like it should be fixed (assuming the authors have both first names and surnames). = Section 2 = "In this case the client SHOULD get an APPENDLIMIT value by issuing a STATUS or LIST command. An IMAP client SHOULD be able to parse both formats. By looking at the upload size advertised by the IMAP server, a client MUST NOT try to APPEND mail more than the advertised limit." The first and last normative requirements here seem too strict considering that this extension basically allows an optimization. That is, if a client decides not to find out the append limit for a particular mailbox using STATUS or LIST, that doesn't seem to create any particular problem. Likewise, it seems better for a client to avoid sending an attachment larger than a known limit, but doing so doesn't seem so problematic as to warrant a MUST NOT. _______________________________________________ imapext mailing list [email protected] https://www.ietf.org/mailman/listinfo/imapext